Author
Listed:
- Kazutoshi Hirose
(The University of Tokyo)
- Satoshi Kodera
(The University of Tokyo)
- Masako Nishikawa
(The University of Tokyo)
- Masataka Sato
(The University of Tokyo)
- Yuqi Zhou
(The University of Tokyo)
- Hongqian Zhang
(The University of Tokyo)
- Shun Minatsuki
(The University of Tokyo)
- Junichi Ishida
(The University of Tokyo)
- Norifumi Takeda
(The University of Tokyo)
- Huidong Wang
(The University of Tokyo)
- Chuiming Kong
(The University of Tokyo)
- Yunjie Deng
(The University of Tokyo)
- Junyu Chen
(The University of Tokyo)
- Chenqi Zhang
(The University of Tokyo)
- Jun Akita
(The University of Tokyo)
- Yuma Ibayashi
(The University of Tokyo)
- Ruoxi Yang
(The University of Tokyo)
- Hiroshi Kanno
(The University of Tokyo
Tohoku University Graduate School of Medicine)
- Nao Nitta
(CYBO Inc)
- Takeaki Sugimura
(CYBO Inc)
- Norihiko Takeda
(The University of Tokyo)
- Makoto Kurano
(The University of Tokyo)
- Yutaka Yatomi
(The University of Tokyo
International University of Health and Welfare Graduate School)
- Keisuke Goda
(The University of Tokyo
CYBO Inc
University of California
Wuhan University)
Abstract
Coronary artery disease (CAD) is a leading cause of death globally. Antiplatelet therapy remains crucial in preventing and treating CAD-associated thrombotic complications, but it concurrently amplifies the risk of bleeding. Unfortunately, traditional platelet function measurement methods cannot directly evaluate its efficacy and safety. Here we demonstrate comprehensive image-based profiling of circulating platelets to directly observe thrombotic conditions and assess antiplatelet therapy in CAD patients. Deep learning-based analysis of whole blood samples from 207 CAD patients revealed elevated concentrations of circulating platelet aggregates, especially in acute versus chronic coronary syndrome patients. It also indicated a regimen-dependent reduction in these concentrations upon treatment with antiplatelet drugs, thereby verifying the direct efficacy of the therapy. Notably, consistent concentrations of these aggregates were found in both venous and arterial blood, suggesting venous blood as a reliable therapy efficacy indicator, despite CAD’s arterial nature. These findings support personalized and improved antiplatelet therapy in CAD management.
Suggested Citation
Kazutoshi Hirose & Satoshi Kodera & Masako Nishikawa & Masataka Sato & Yuqi Zhou & Hongqian Zhang & Shun Minatsuki & Junichi Ishida & Norifumi Takeda & Huidong Wang & Chuiming Kong & Yunjie Deng & Jun, 2025.
"Direct evaluation of antiplatelet therapy in coronary artery disease by comprehensive image-based profiling of circulating platelets,"
Nature Communications, Nature, vol. 16(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59664-8
DOI: 10.1038/s41467-025-59664-8
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:16:y:2025:i:1:d:10.1038_s41467-025-59664-8. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.